Research Reports Library
Here you will find copies of HDSA Research Reports that have been featured on the HDSA website and in our print publications. To read or download a report just click on the title.
An HDAC inhibitor ameliorates pathology in the R6/2 mice
Inhibitors of cytochrome c have therapeutic potential
CEP-1347 is added to the research pipeline
The Hereditary Disease Foundation Conference 2008
A New Stem Cell Line for HD: Another Model of the Disease
Immune System Over-Activated in HD
The FDA Approves a Phase IIb Clinical Trial of ACR16
Dimebon found safe and well tolerated in a Phase II trial
Sertaline helps two mouse models of HD
Raptor Pharmaceuticals Plan Phase II trial of Cysteamine
ALS clinical trial finds that minocycline accelerates disease progression
The Inaugural HSG Clinical Research Symposium
DIMOND (Dimebon Phase 2 Clinical Research Study) is Recruiting
first large transgenic animal model for Huntington's disease
Huntington Study Group Meetings Starting the Old and Planning for the New
Enrollment for DIMOND was completed in March 2008. Dimebon clinical trial is recruiting.
2008 CHDI HD Therapeutics Conference - A Report from an HD Family Perspective
Drugs which induce autophagy are added to the research pipeline
Early Neurotransmitter Problems in HD
Physical activity delays onset of motor symptoms in the R6/1 mouse model of HD
ALS clinical trial finds that minocycline accelerates disease progression
The Huntington’s Disease Community’s Strategic Plan for the Cure
The Huntington’s Disease Community’s Strategic Plan for the Cure
The Huntington’s Disease Community’s Strategic Plan for the Cure
Yerkes researchers develop first transgenic nonhuman primate model of Huntington's disease